human epidermal growth factor receptor 2-positive breast cancer following progression on trastuzumab and a taxane. The safety profile of T-DM1 was consistent with prior experience.

Publications regarding the 100 top-cited articles in a given discipline are common, but studies reporting the association between article topics and their citations…[Read more]

hich may be a promising therapeutic approach for tendon injury.

A growing body of research highlights the pervasive harms of adverse childhood experiences (ACEs) on health throughout the life-course. However, findings from prior reviews and recent longitudinal studies investigating the association between types of ACEs and persistent pain have…[Read more]

Understanding the importance of using personal protective equipment (PPE) and the influence of work-post (working distance to main dust source-crusher) in stone quarries is vital for designing tailored interventions in minimizing workers’ exposure to silica dust. Nonetheless, studies on silica dust and disease symptoms in Ghana are nascent. This…[Read more]

The baseline mean BDV of the control, 5-, and 10-mg acemannan groups were not significantly different (

 > 0.05). After treatment, the mean BDV for each group was reduced in a time-dependent manner. Compared with the control group, the 5- and 10-mg acemannan groups had a significantly greater %ΔBDV (approximately 2- and 1.89-fold) at 3-mo…[Read more]